Pharmacologic Contributors to Patent Ductus Arteriosus
动脉导管未闭的药理学贡献者
基本信息
- 批准号:10444540
- 负责人:
- 金额:$ 72.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Adverse effectsAffectAminoglycosidesAnemiaAnimalsAntacidsAntibioticsAortaAreaBiological AssayBirthBlood VesselsChronicChronic lung diseaseComplexCritical IllnessCyclooxygenase InhibitorsDataDatabasesDevelopmentDiseaseDiureticsDrug CombinationsDrug ExposureDrug ScreeningDrug toxicityDrug usageDuctus ArteriosusEvaluationExposure toFailureFurosemideGentamicinsGrantHumanHypoxiaImpairmentIn VitroKidneyKnowledgeLifeLigationLiquid substanceMediatingMolecularMorbidity - disease rateMusMuscle ContractionMyographyNeonatalNeonatal Intensive Care UnitsNewborn AnimalsNewborn InfantOperative Surgical ProceduresPatent Ductus ArteriosusPathway interactionsPharmaceutical PreparationsPharmacological TreatmentPharmacologyPharmacopoeiasPhasePhysiologicalPregnancyPremature InfantPropertyProstaglandin-Endoperoxide SynthaseProstaglandinsPulmonary artery structureRelaxationResearchRiskRisk FactorsSepsisSeriesShunt DeviceSignal TransductionSmooth MuscleSmooth Muscle MyocytesStimulusTestingTherapeuticTimeToxic effectTransfusionUterusVasoconstrictor AgentsVasodilator AgentsWomanbaseclinically relevantconstrictioncytotoxicitydrug candidatefetalfetal bloodgene networkhigh risk infanthigh throughput screeninghuman datahuman tissuein vivoinnovationinterestmodifiable riskmortalitymouse modelneonatal humanneonatal miceneonatenovelpostnatalprematureprenatal exposurepressurepreterm newbornpreventscreeningsealskillstranslational potential
项目摘要
Project Summary
Vascular adaptation after birth is dependent on closure of the ductus arteriosus (DA), a fetal vascular shunt
connecting the pulmonary artery and aorta. Failure of DA closure results in persistent patency of the DA (PDA),
a common disorder associated with increased morbidity and mortality in the most vulnerable infants. Current
pharmacological treatments for PDA are limited and only focus on a single therapeutic pathway –
cyclooxygenase-mediated prostaglandin (PG) synthesis. However, recent data reveal complex networks of
genes and druggable pathways involved in the vasodilatory-to-vasoconstrictive shift that drives postnatal DA
closure. Efforts to identify new DA-selective vasoconstrictors overlook the possibility that ongoing vasodilatory
stimuli perpetuate DA relaxation and inhibit its closure. Because critically ill preterm newborns are exposed to
multiple medications during the time that DA closure takes place, we postulate that pharmacologic agents used
in the neonatal ICU prevent DA closure and contribute to PDA.
The DA of prematurely-born infants is developmentally primed to respond to vasodilatory signals. Our prior
studies using mouse models and human data show that drugs frequently used in preterm infants have
unexpected vasodilatory effects on the DA, including specific antibiotics, antacids, and diuretics. These data
suggest that drug-induced DA relaxation is a modifiable contributor to PDA, but this has not been systematically
evaluated. We therefore hypothesize that drugs commonly used in the NICU have an adverse effect on
closure of the premature DA and that specific drug combinations act synergistically to impair postnatal
DA closure. Mouse and human tissues will be used to test this hypothesis in three Aims: 1) Determine whether
drugs in the neonatal pharmacopeia prevent the initial phase of DA closure - smooth muscle constriction - that
leads to physiologic closure of the DA lumen; 2) Determine whether drugs in the neonatal pharmacopeia impair
the second phase of DA closure - fibromuscular remodeling - that leads to permanent sealing of the constricted
DA; 3) Identify drug combinations that interact to adversely affect either phase of DA closure. Drug effects will
be examined using primary (in vitro) high throughput screening (HTS) of preterm mouse DA smooth muscle
cells. A series of secondary screening assays will prioritize single- and synergistic combinations of hits based
on potency/efficacy, DA-selectivity, and toxicity for further study of their ex vivo and in vivo vasoactive effects on
the DA. A novel ex vivo mouse DA-reopening assay will be used to screen for drugs of interest. The effect of hit
DA-vasodilatory compounds will be examined on ex vivo human neonatal DA segments and in a large national
database of preterm infants. These studies have high translational potential and will definitively identify which
drugs or drug combinations pose increased risks for PDA in preterm infants, providing an innovative approach
to enhance conservative PDA management efforts in the NICU.
项目摘要
出生后的血管适应依赖于动脉导管(DA)的闭合,这是一种胎儿血管分流
连接肺动脉和主动脉DA闭合失败导致DA(PDA)持续通畅,
这是一种常见的疾病,与最脆弱婴儿的发病率和死亡率增加有关。电流
PDA的药物治疗有限,仅关注单一治疗途径-
环加氧酶介导的前列腺素(PG)合成。然而,最近的数据显示,
基因和药物途径参与了驱动出生后DA的血管舒张到血管收缩的转变
结束努力确定新的DA选择性血管收缩剂忽略了正在进行的血管舒张的可能性,
刺激使DA松弛永久化并抑制其闭合。因为重症早产儿会接触到
在DA关闭发生的时间内使用多种药物,我们假设使用的药物
在新生儿重症监护室预防DA关闭并导致PDA。
早产儿的DA在发育过程中会对血管舒张信号做出反应。我们事先
使用小鼠模型和人类数据的研究表明,经常用于早产儿的药物
对DA的意外血管舒张作用,包括特定抗生素、抗酸剂和利尿剂。这些数据
提示药物引起DA松弛是PDA的一个可改变的因素,但这还没有被系统地
评估。因此,我们假设NICU中常用的药物对
关闭过早的DA和特定的药物组合协同作用,损害产后
DA关闭。小鼠和人体组织将用于在三个目的中测试该假设:1)确定是否
新生儿药典中的药物可以预防DA闭合的初始阶段-平滑肌收缩,
导致DA管腔的生理性闭合; 2)确定新生儿药典中的药物是否损害
DA闭合的第二阶段-纤维肌重塑-导致收缩的
3)确定相互作用对DA关闭的任一阶段产生不利影响的药物组合。药物作用将
使用早产小鼠DA平滑肌的初级(体外)高通量筛选(HTS)进行检查
细胞一系列的二次筛选试验将优先考虑单一和协同组合的命中,
对效价/有效性、DA选择性和毒性的影响,以进一步研究其离体和体内血管活性作用,
一种新的离体小鼠DA-再开放测定将用于筛选感兴趣的药物。打击的效果
DA-血管舒张化合物将在离体人新生儿DA节段和大型国家实验中进行检查。
早产儿数据库这些研究具有很高的转化潜力,将明确确定
药物或药物组合增加了早产儿PDA的风险,提供了一种创新的方法,
加强NICU中PDA的保守治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Jeffrey Reese其他文献
John Jeffrey Reese的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Jeffrey Reese', 18)}}的其他基金
Pharmacologic Contributors to Patent Ductus Arteriosus
动脉导管未闭的药理学贡献者
- 批准号:
10653150 - 财政年份:2022
- 资助金额:
$ 72.01万 - 项目类别:
Preventing Prematurity and Poor Pregnancy Outcomes Training Grant
预防早产和不良妊娠结局培训补助金
- 批准号:
8658837 - 财政年份:2011
- 资助金额:
$ 72.01万 - 项目类别:
Preventing Prematurity and Poor Pregnancy Outcomes Training Grant
预防早产和不良妊娠结局培训补助金
- 批准号:
8470673 - 财政年份:2011
- 资助金额:
$ 72.01万 - 项目类别:
Role of natriuretic peptides in the ductus arteriosus
利尿钠肽在动脉导管中的作用
- 批准号:
8235789 - 财政年份:2010
- 资助金额:
$ 72.01万 - 项目类别:
Role of natriuretic peptides in the ductus arteriosus
利尿钠肽在动脉导管中的作用
- 批准号:
8060572 - 财政年份:2010
- 资助金额:
$ 72.01万 - 项目类别:
Role of natriuretic peptides in the ductus arteriosus
利尿钠肽在动脉导管中的作用
- 批准号:
8442344 - 财政年份:2010
- 资助金额:
$ 72.01万 - 项目类别:
Role of natriuretic peptides in the ductus arteriosus
利尿钠肽在动脉导管中的作用
- 批准号:
7887939 - 财政年份:2010
- 资助金额:
$ 72.01万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 72.01万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 72.01万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 72.01万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 72.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




